Honeywell International Inc. vs Xylem Inc. — Stock Comparison
Q·Score Breakdown
6.8
Neutral
Overall
7.5
Bullish
Quality
Health
Growth
Valuation
Sentiment
HON
High-quality business with 24% return on equity and 11% profit margins.
⚠ earnings contracting 42% year-over-year.
XYL
Consensus analyst target of $150.82 is 31% above current price.
Analyst Consensus
BUY
Target $247.90 (+16.7%)
25 analysts
BUY
Target $150.82 (+30.7%)
17 analysts
Fundamentals
HON
XYL
33.9×
Trailing P/E
28.8×
18.5×
Forward P/E
19.0×
10.9%
Profit Margin
10.8%
36.9%
Gross Margin
38.6%
24.3%
ROE
8.7%
2.4%
Revenue Growth
2.7%
-41.9%
Earnings Growth
14.5%
0.92
Beta
1.17
—
Price / Book
—
$134.7B
Market Cap
$27.4B
$187 – $248
52-Week Range
$114 – $154
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →